Report Detail

Pharma & Healthcare Global Gastroesophageal Reflux Disease Therapeutics Market Insights, Forecast to 2025

  • RnM2312773
  • |
  • 07 August, 2018
  • |
  • Global
  • |
  • 99 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Gastroesophageal Reflux Disease Therapeutics Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Antacids
      • 1.4.3 H2 Receptor Blockers
      • 1.4.4 Proton Pump Inhibitors (PPIs)
      • 1.4.5 Pro-kinetic Agents
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application: 2020 VS 2026
      • 1.5.2 Hospital Pharmacy
      • 1.5.3 Drug Stores
      • 1.5.4 General Stores
      • 1.5.5 Supermarkets
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Gastroesophageal Reflux Disease Therapeutics Market Perspective (2015-2026)
    • 2.2 Gastroesophageal Reflux Disease Therapeutics Growth Trends by Regions
      • 2.2.1 Gastroesophageal Reflux Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Gastroesophageal Reflux Disease Therapeutics Historic Market Share by Regions (2015-2020)
      • 2.2.3 Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Gastroesophageal Reflux Disease Therapeutics Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Gastroesophageal Reflux Disease Therapeutics Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Market Size
      • 3.1.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue (2015-2020)
      • 3.1.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio
      • 3.2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease Therapeutics Revenue in 2019
    • 3.3 Gastroesophageal Reflux Disease Therapeutics Key Players Head office and Area Served
    • 3.4 Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service
    • 3.5 Date of Enter into Gastroesophageal Reflux Disease Therapeutics Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Type (2015-2020)
    • 4.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2021-2026)

    5 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Application (2015-2026)

    • 5.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)
    • 5.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
    • 6.2 Gastroesophageal Reflux Disease Therapeutics Key Players in North America (2019-2020)
    • 6.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
    • 6.4 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
    • 7.2 Gastroesophageal Reflux Disease Therapeutics Key Players in Europe (2019-2020)
    • 7.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
    • 7.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

    8 China

    • 8.1 China Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
    • 8.2 Gastroesophageal Reflux Disease Therapeutics Key Players in China (2019-2020)
    • 8.3 China Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
    • 8.4 China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
    • 9.2 Gastroesophageal Reflux Disease Therapeutics Key Players in Japan (2019-2020)
    • 9.3 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
    • 9.4 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
    • 10.2 Gastroesophageal Reflux Disease Therapeutics Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

    11 India

    • 11.1 India Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
    • 11.2 Gastroesophageal Reflux Disease Therapeutics Key Players in India (2019-2020)
    • 11.3 India Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
    • 11.4 India Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
    • 12.2 Gastroesophageal Reflux Disease Therapeutics Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
    • 12.4 Central & South America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 AstraZeneca
      • 13.1.1 AstraZeneca Company Details
      • 13.1.2 AstraZeneca Business Overview and Its Total Revenue
      • 13.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020))
      • 13.1.5 AstraZeneca Recent Development
    • 13.2 Eisai
      • 13.2.1 Eisai Company Details
      • 13.2.2 Eisai Business Overview and Its Total Revenue
      • 13.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.2.4 Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
      • 13.2.5 Eisai Recent Development
    • 13.3 Takeda Pharmaceutical
      • 13.3.1 Takeda Pharmaceutical Company Details
      • 13.3.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
      • 13.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.3.4 Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
      • 13.3.5 Takeda Pharmaceutical Recent Development
    • 13.4 GlaxoSmithKline
      • 13.4.1 GlaxoSmithKline Company Details
      • 13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
      • 13.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.4.4 GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
      • 13.4.5 GlaxoSmithKline Recent Development
    • 13.5 Johnson & Johnson
      • 13.5.1 Johnson & Johnson Company Details
      • 13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
      • 13.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
      • 13.5.5 Johnson & Johnson Recent Development
    • 13.6 Daewoong Pharmaceutical
      • 13.6.1 Daewoong Pharmaceutical Company Details
      • 13.6.2 Daewoong Pharmaceutical Business Overview and Its Total Revenue
      • 13.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.6.4 Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
      • 13.6.5 Daewoong Pharmaceutical Recent Development
    • 13.7 Ironwood Pharmaceuticals
      • 13.7.1 Ironwood Pharmaceuticals Company Details
      • 13.7.2 Ironwood Pharmaceuticals Business Overview and Its Total Revenue
      • 13.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.7.4 Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
      • 13.7.5 Ironwood Pharmaceuticals Recent Development
    • 13.8 Rottapharm Madaus
      • 13.8.1 Rottapharm Madaus Company Details
      • 13.8.2 Rottapharm Madaus Business Overview and Its Total Revenue
      • 13.8.3 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.8.4 Rottapharm Madaus Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
      • 13.8.5 Rottapharm Madaus Recent Development
    • 13.9 Peer Medical
      • 13.9.1 Peer Medical Company Details
      • 13.9.2 Peer Medical Business Overview and Its Total Revenue
      • 13.9.3 Peer Medical Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.9.4 Peer Medical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
      • 13.9.5 Peer Medical Recent Development
    • 13.10 Reviva Pharmaceuticals
      • 13.10.1 Reviva Pharmaceuticals Company Details
      • 13.10.2 Reviva Pharmaceuticals Business Overview and Its Total Revenue
      • 13.10.3 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction
      • 13.10.4 Reviva Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
      • 13.10.5 Reviva Pharmaceuticals Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Gastroesophageal Reflux Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastroesophageal Reflux Disease Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      AstraZeneca
      Eisai
      Takeda Pharmaceutical
      GlaxoSmithKline
      Johnson & Johnson
      Daewoong Pharmaceutical
      Ironwood Pharmaceuticals
      Rottapharm Madaus
      Peer Medical
      Reviva Pharmaceuticals

      Market segment by Type, the product can be split into
      Antacids
      H2 Receptor Blockers
      Proton Pump Inhibitors (PPIs)
      Pro-kinetic Agents
      Others
      Market segment by Application, split into
      Hospital Pharmacy
      Drug Stores
      General Stores
      Supermarkets

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gastroesophageal Reflux Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Gastroesophageal Reflux Disease Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Gastroesophageal Reflux Disease Therapeutics are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Gastroesophageal Reflux Disease Therapeutics . Industry analysis & Market Report on Gastroesophageal Reflux Disease Therapeutics is a syndicated market report, published as Global Gastroesophageal Reflux Disease Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Gastroesophageal Reflux Disease Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,102.85
      4,654.27
      6,205.70
      3,479.40
      5,219.10
      6,958.80
      424,171.80
      636,257.70
      848,343.60
      294,181.68
      441,272.52
      588,363.36
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report